Slowing the heart saves lives: Advantages of perioperative β-blockade

British Journal of Surgery

Volumn 87, Issue 6, 2000, Pages 689-690

  Jones, K G ^a   Powell, J T ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL;

EDITORIAL; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART RATE; HIGH RISK PATIENT; HUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0034122594     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2000.01516.x     Document Type: Editorial

References (4)

1. 1 L'Italien GJ, Paul SD, Hendel RC, Leppo JA, Cohen MC, Fleisher LA et al. Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1081 vascular surgical candidates. J Am Coll Cardiol 1996 ; 27: 779–86.
2. 2 Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicentre Study of Perioperative Ischaemia Research Group. N Engl J Med 1996 ; 335: 1713–20.
3. 3 Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankenstijn JD et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high‐risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999 ; 341: 1789–94.
4. 4 Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999 ; 100: 1043–9.